Testing digital thinking and memory tests for people with CNS lymphoma or low-grade glioma
Original title: Neurocognitive Assessment CNSL and LGG
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
No phase is listed for this study, so it is still being tested in people.
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study checks whether thinking and memory tests you take on your own can work as well as the standard tests given by a specialist.
Who this trial is for. This trial is for people with primary central nervous system lymphoma or a low-grade glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary. It tests digital thinking and memory tests that a person takes on their own, and compares them with the established neuropsychological tests.
Where it stands. This trial has not reported results. It is measuring how accurate and reliable the self-given digital tests are compared with the established tests. That answer is not in yet.
What this means, and what it doesn't
What it could mean: This study is about how thinking and memory get checked. It is not testing a new treatment. If the digital tests hold up, checking thinking and memory may become simpler. Someone who fits this study could ask their care team about it.
What it doesn't mean: This does not mean the digital tests are proven. A trial is a test, not a proven treatment. Taking part in one is not a guarantee that it will help you. It is not a promise of a cure.
Source: ClinicalTrials.gov, July 17, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.